CARISOPRODOL

Substance profile for UNII 21925K482H, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CARISOPRODOL
Structure render from PubChem CID 2576

Substance Identity#

UNII
21925K482H
Preferred term
CARISOPRODOL
Registry number
78-44-4
EC number
201-118-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C12H24N2O4
Chemical structure for CARISOPRODOL
Structure render from PubChem CID 2576

Chemical And Database Identifiers#

SMILES
CCCC(C)(COC(N)=O)COC(=O)NC(C)C
RxCUI
2101
PubChem
2576
NCIt
C28904
INN ID
902

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL2
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19592
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19592
CARISOPRODOLACTIVE INGREDIENT21925K482H3197e424-ac97-4667-b64d-503581f5edc11
CARISOPRODOLACTIVE MOIETY21925K482H3197e424-ac97-4667-b64d-503581f5edc11
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19592
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19592
CarisoprodolACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use CARISOPRODOL tablets USP safely and effectively. See full prescribing information for carisoprodol. CARISOPRODOL tablets, USP for oral use, C-IV Initial U.S. Approval: 19598
CarisoprodolACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use CARISOPRODOL tablets USP safely and effectively. See full prescribing information for carisoprodol. CARISOPRODOL tablets, USP for oral use, C-IV Initial U.S. Approval: 19598
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19593
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19593
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HCarisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
CARISOPRODOLACTIVE MOIETY21925K482HCarisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
CARISOPRODOLACTIVE MOIETY21925K482HCarisoprodol Tablets, USP C-IV Rx Only These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HCarisoprodol Tablets, USP C-IV Rx Only These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19593
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19593
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
CARISOPRODOLACTIVE INGREDIENT21925K482HCarisoprodol Tablets, USP Rx only Rev. 09/09 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Initial U.S. Approval Carisoprodol Tablets for Oral use18
CARISOPRODOLACTIVE MOIETY21925K482HCarisoprodol Tablets, USP Rx only Rev. 09/09 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Initial U.S. Approval Carisoprodol Tablets for Oral use18
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19595
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19595
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL AND ASPIRIN 200MG/325MG USP Rx Only1
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL AND ASPIRIN 200MG/325MG USP Rx Only1
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
CARISOPRODOLACTIVE MOIETY21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19592
CARISOPRODOLACTIVE INGREDIENT21925K482HThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19592
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
CARISOPRODOLACTIVE INGREDIENT21925K482HSOMA (CARISOPRODOL ) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3830
CARISOPRODOLACTIVE MOIETY21925K482HSOMA (CARISOPRODOL ) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3830
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [QUALITEST PHARMACEUTICALS]18
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [QUALITEST PHARMACEUTICALS]18
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [WATSON LABORATORIES, INC.]16
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [WATSON LABORATORIES, INC.]16
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]13
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]13
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [AUROBINDO PHARMA LIMITED]10
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [AUROBINDO PHARMA LIMITED]10
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]10
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]10
CARISOPRODOLACTIVE MOIETY21925K482HSOMA (CARISOPRODOL ) TABLET [MEDA PHARMACEUTICALS INC.]9
CARISOPRODOLACTIVE INGREDIENT21925K482HSOMA (CARISOPRODOL ) TABLET [MEDA PHARMACEUTICALS INC.]9
CarisoprodolACTIVE MOIETY21925K482HCARISOPRODOL TABLET [MIRROR PHARMACEUTICALS LLC]7
CarisoprodolACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [MIRROR PHARMACEUTICALS LLC]7
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [UNIT DOSE SERVICES]7
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [UNIT DOSE SERVICES]7
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]6
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]6
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL AND ASPIRIN TABLET [EON LABS, INC.]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL AND ASPIRIN TABLET [EON LABS, INC.]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [AMERICAN HEALTH PACKAGING]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [AMERICAN HEALTH PACKAGING]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [CARDINAL HEALTH]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [CARDINAL HEALTH]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [PROFICIENT RX LP]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [PROFICIENT RX LP]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL AND ASPIRIN TABLET [HERITAGE PHARMACEUTICALS INC.]4
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL AND ASPIRIN TABLET [HERITAGE PHARMACEUTICALS INC.]4
CarisoprodolACTIVE MOIETY21925K482HCARISOPRODOL AND ASPIRIN TABLET [MIRROR PHARMACEUTICALS LLC]4
CarisoprodolACTIVE INGREDIENT21925K482HCARISOPRODOL AND ASPIRIN TABLET [MIRROR PHARMACEUTICALS LLC]4
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [APOTHECA, INC.]4
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [APOTHECA, INC.]4
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [EON LABS, INC.]4
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [EON LABS, INC.]4
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL (CARISOPRODOL ) TABLET [WALLACE PHARMACEUTICALS INC.]3
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL (CARISOPRODOL ) TABLET [WALLACE PHARMACEUTICALS INC.]3
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL IMMEDIATE RELEASE (CARISOPRODOL) TABLET [VENSUN PHARMACEUTICALS, INC]3
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL IMMEDIATE RELEASE (CARISOPRODOL) TABLET [VENSUN PHARMACEUTICALS, INC]3
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]3
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [BRYANT RANCH PREPACK]3
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [RISING PHARMACEUTICALS, INC.]3
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [RISING PHARMACEUTICALS, INC.]3
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [BIONPHARMA INC.]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [BIONPHARMA INC.]2
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [CARDINAL HEALTH]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [CARDINAL HEALTH]2
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [MEDSOURCE PHARMACEUTICALS]2
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [MEDSOURCE PHARMACEUTICALS]2
CarisoprodolACTIVE MOIETY21925K482HCARISOPRODOL TABLET [ORIENT PHARMA CO., LTD.]2
CarisoprodolACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [ORIENT PHARMA CO., LTD.]2